Panaro, Maria Antonietta

Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells. [electronic resource] - The British journal of nutrition Nov 2012 - 1623-32 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1475-2662

10.1017/S0007114511007227 doi


Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Antineoplastic Agents, Phytogenic--adverse effects
Caco-2 Cells
Cell Line, Tumor
Cell Survival
Colonic Neoplasms--immunology
Dietary Supplements--adverse effects
Down-Regulation
Enterocytes--cytology
Humans
I-kappa B Proteins--metabolism
Inflammatory Bowel Diseases--diet therapy
Lipopolysaccharides
NF-kappa B--antagonists & inhibitors
Nitric Oxide--metabolism
Nitric Oxide Synthase Type II--genetics
Phosphorylation
Protein Processing, Post-Translational
Proteolysis
RNA, Messenger--metabolism
Resveratrol
Stilbenes--adverse effects
Toll-Like Receptor 4--genetics